Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System
CompanyMedical Device

Suzhou Sinus Medtech Wins FDA Breakthrough Designation for oHCM Ablation System

Novartis' PSMAddition Trial Yields Positive Results for Pluvicto in mHSPC
CompanyDrug

Novartis’ PSMAddition Trial Yields Positive Results for Pluvicto in mHSPC

Innovent Biologics' Xinbiyue Approved for Macau Market
CompanyDrug

Innovent Biologics’ Xinbiyue Approved for Macau Market

Innogen Pharma Resubmits Hong Kong IPO Application With Promising Diabetes Drug
CompanyDeals

Innogen Pharma Resubmits Hong Kong IPO Application With Promising Diabetes Drug

Harrow Signs Licensing Deal for Formosa's Byqlovi in US Market
CompanyDeals

Harrow Signs Licensing Deal for Formosa’s Byqlovi in US Market

FDA Approves Merck's Enflonsia for Infant RSV Protection
CompanyDrug

FDA Approves Merck’s Enflonsia for Infant RSV Protection

Sino Biopharmaceutical Gains CDE Approval for TQC3721 COPD Trial
CompanyDrug

Sino Biopharmaceutical Gains CDE Approval for TQC3721 COPD Trial

Huadong Medicine's HDM1010 Gets FDA Nod for Phase I Trial in T2D
CompanyDrug

Huadong Medicine’s HDM1010 Gets FDA Nod for Phase I Trial in T2D

Sanyou Biopharma Partners with Medicovestor to Advance Next-Gen ADCs
CompanyDeals

Sanyou Biopharma Partners with Medicovestor to Advance Next-Gen ADCs

Huahai Pharma Receives FDA Warning Letter After Inspection
Company

Huahai Pharma Receives FDA Warning Letter After Inspection

Burning Rock Reports Q1 2025 Revenue Growth and R&D Progress
Company

Burning Rock Reports Q1 2025 Revenue Growth and R&D Progress

Sinopep Allsino Partners with Vazyme to Advance Synthetic Biology
CompanyDeals

Sinopep Allsino Partners with Vazyme to Advance Synthetic Biology